UPDATE 1-Merck up as Zetia trial less damaging than feared

UPDATE 1-Merck up as Zetia trial less damaging than feared
Reuters - 18 hours ago
By Toni Clarke BOSTON, Nov. 16 (Reuters) - Shares of Merck & Co Inc (MRK.N) rose 2.7 percent on Monday after results of a clinical trial of its cholesterol drug Zetia were not as negative as some ...
Merck, Abbott Rise After Cholesterol-Drug Study - CNNMoney.com
Merck Cholesterol Woes May Rise on Loss to Abbott - Bloomberg
MSN Money
- Newser
- Easy Bourse